[Modification of central nervous system resistance against anoxia using various metabolic substrates and enzyme inhibitors during ontogenesis].
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001152:Arsenicals / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects / Q000276:immunology*; D003486:Cyanides / Q000494:pharmacology; D004791:Enzyme Inhibitors; D005947:Glucose / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology; D000860:Hypoxia / Q000276:immunology*; D007109:Immunity / Q000187:drug effects; D007454:Iodides / Q000494:pharmacology; D007773:Lactates / Q000494:pharmacology; D008314:Malonates / Q000494:pharmacology; D011773:Pyruvates / Q000494:pharmacology; D051381:Rats / Q000254:growth & development*; D012964:Sodium
D000085:Acetates; D001152:Arsenicals; D003486:Cyanides; D004791:Enzyme Inhibitors; D005971:Glutamates; D007454:Iodides; D007773:Lactates; D008314:Malonates; D011773:Pyruvates; D012964:Sodium; D005947:Glucose
Ovlivnĕní odolnosti centrálhího nervového systému proti anxii nĕkterými metabolickými substráty a enzymovými inhibitory v průbĕhu ontogenese.